150 studies found for:    Chorea
Show Display Options
Rank Status Study
21 Completed Different Dyskinesias in Parkinson's Disease and Their Relation to Levodopa Pharmacokinetics
Conditions: Parkinson Disease;   Dyskinesias
Intervention: Drug: levodopa/carbidopa
22 Completed TREND-HD - A Trial of Ethyl-EPA (Miraxion™) in Treating Mild to Moderate Huntington's Disease
Condition: Huntington Disease
Intervention: Drug: Ethyl-EPA (Miraxion™)
23 Recruiting (+)-Alpha-Dihydrotetrabenazine Phase I
Condition: Healthy Subjects
Intervention: Drug: HTBZ
24 Completed Comparative 2-D Tumor Analysis in Familial Gliomas
Condition: Malignant Glioma
Intervention:
25 Recruiting Brain Imaging of Childhood Onset Psychiatric Disorders, Endocrine Disorders and Healthy Volunteers
Conditions: XXY (Klinefelter);   Sex Chromosome Variation;   Sex Chromosome Aneuploidy;   XXXY;   XXXXXY;   XYY (Jacob);   XXYY;   X (XO, Turner);   XXX (Trisomy X, Triple X);   XXXX (Tetrasomy X);   XXXXX (Pentasomy X)
Intervention:
26 Recruiting I2PETPG - Imidazoline2 Binding Sites in a Group of Participants Diagnosed With AD
Condition: Alzheimer Disease
Interventions: Radiation: [11C]BU99008;   Drug: Idazoxan
27 Completed I2PETHV - Imidazoline2 Binding Site in Healthy Volunteers
Conditions: Healthy Volunteers;   Alzheimer Disease;   Molecular Imaging
Interventions: Radiation: [11C]BU99008;   Drug: Idazoxan;   Drug: Isocarboxazid
28 Recruiting WILSTIM - DBS (WILson STIMulation - Deep Brain Stimulation)
Conditions: Severe Dystonia;   Wilson's Disease
Interventions: Device: Medtronic, Activa® PC "on";   Device: Medtronic, Activa® PC "off"
29 Not yet recruiting Finding Genes With NGS Techniques in Whom Mutations Cause Neurological Diseases
Condition: Neurological Diseases
Intervention: Genetic: Genetic testing
30 Unknown  Dopamine Treatment in Children With Cerebral Palsy With Dystonia- A Double Blind Controlled Study
Condition: Dystonic Cerebral Palsy
Interventions: Drug: L- DOPA;   Drug: placebo
31 Completed Preventive Measures for Childhood-Onset Obsessive-Compulsive Disorder and Tic Disorders (PANDAS Subgroup)
Conditions: Mental Disorder Diagnosed in Childhood;   Obsessive Compulsive Disorder;   Streptococcal Infection;   Tic Disorder
Intervention: Drug: Penicillin or Placebo
32 Enrolling by invitation Brain Stimulation in Movement Disorders
Conditions: Huntington's Disease;   Tourette Syndrome
Intervention: Other: Transcranial direct current stimulation
33 Available Compassionate Use of Tetrabenazine in the Treatment of Abnormal Movements
Condition: Hyperkinetic Movement Disorders
Intervention: Drug: tetrabenazine
34 Unknown  Exploring Hypertonia in Children With Cerebral Palsy
Condition: Cerebral Palsy.
Intervention: Other: No intervention applicable
35 Recruiting Botulinum Toxin for the Treatment of Involuntary Movement Disorders
Conditions: Chorea;   Drug Induced Dyskinesia;   Movement Disorder;   Muscular Disease;   Tic Disorder
Intervention: Other: Botulinum Toxin
36 Active, not recruiting Far Infrared Irradiation for Managing, Control and Treatment of Huntington's Disease (HD)
Condition: Huntington Disease
Intervention: Radiation: Far Infrared Radiation
37 Active, not recruiting Ursodiol in Huntington's Disease
Condition: Huntington Disease
Interventions: Drug: ursodiol;   Drug: placebo
38 Completed A Open-label Food Effect Study With SEN0014196 in Subjects With Huntington Disease
Condition: Huntington's Disease
Intervention: Drug: SEN0014196
39 Completed An Exploratory Clinical Trial in Early Stage Huntington's Disease Patients With SEN0014196
Condition: Huntington Disease
Interventions: Drug: SEN0014196 (Low Dose);   Drug: SEN0014196 (High Dose);   Drug: Placebo
40 Withdrawn Treating Sleep/Wake Cycle Disturbances in Basal Ganglia Disorders With Ramelteon
Conditions: Huntington's Disease;   Parkinson's Disease;   Dementia With Lewy Bodies;   Sleep Disorders;   Circadian Dysregulation
Interventions: Drug: Ramelteon;   Drug: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.